The role of S-nitrosoglutathione reductase (GSNOR) in human disease and therapy

Abstract S-nitrosoglutathione reductase (GSNOR), or ADH5, is an enzyme in the alcohol dehydrogenase (ADH) family. It is unique when compared to other ADH enzymes in that primary short-chain alcohols are not its principle substrate. GSNOR metabolizes S-nitrosoglutathione (GSNO), S-hydroxymethylglutathione (the spontaneous adduct of formaldehyde and glutathione), and some alcohols. GSNOR modulates reactive nitric oxide (•NO) availability in the cell by catalyzing the breakdown of GSNO, and indirectly regulates S-nitrosothiols (RSNOs) through GSNO-mediated protein S-nitrosation. The dysregulation of GSNOR can significantly alter cellular homeostasis, leading to disease. GSNOR plays an important regulatory role in smooth muscle relaxation, immune function, inflammation, neuronal development and cancer progression, among many other processes. In recent years, the therapeutic inhibition of GSNOR has been investigated to treat asthma, cystic fibrosis and interstitial lung disease (ILD). The direct action of •NO on cellular pathways, as well as the important regulatory role of protein S-nitrosation, is closely tied to GSNOR regulation and defines this enzyme as an important therapeutic target.

[1]  B. Persson,et al.  Computational studies of human class V alcohol dehydrogenase - the odd sibling , 2016, BMC Biochemistry.

[2]  D. Giustarini,et al.  Biomarkers of oxidative damage in human disease. , 2006, Clinical chemistry.

[3]  S. Matecki,et al.  Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy , 2010, Proceedings of the National Academy of Sciences.

[4]  M. Szmitkowski,et al.  [Alcohol dehydrogenase and the metabolism of ethanol in the brain]. , 2007, Postepy higieny i medycyny doswiadczalnej.

[5]  R. Cole,et al.  Identification and Quantification of S-Nitrosylation by Cysteine Reactive Tandem Mass Tag Switch Assay* , 2011, Molecular & Cellular Proteomics.

[6]  J. Tamargo,et al.  Cardiac electrophysiological effects of nitric oxide. , 2010, Cardiovascular research.

[7]  M. Adinolfi,et al.  Immunological and biochemical characterization of the human alcohol dehydrogenase chi-ADH isozyme. , 1984, Annals of Human Genetics.

[8]  R. Radi,et al.  Peroxynitrite reactivity with amino acids and proteins , 2003, Amino Acids.

[9]  S. Navani,et al.  The human protein atlas , 2011 .

[10]  B. Gaston,et al.  Compartmentalized Connexin 43 S-Nitrosylation/Denitrosylation Regulates Heterocellular Communication in the Vessel Wall , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[11]  E. Aranda,et al.  Altered S-nitrosothiol homeostasis provides a survival advantage to breast cancer cells in HER2 tumors and reduces their sensitivity to trastuzumab. , 2016, Biochimica et biophysica acta.

[12]  Yu-Ju Chen,et al.  Methods for detection and characterization of protein S-nitrosylation. , 2013, Methods.

[13]  M. Walsh,et al.  The myosin phosphatase targeting protein (MYPT) family: a regulated mechanism for achieving substrate specificity of the catalytic subunit of protein phosphatase type 1δ. , 2011, Archives of biochemistry and biophysics.

[14]  A. Hausladen,et al.  Identification of S-nitroso-CoA reductases that regulate protein S-nitrosylation , 2014, Proceedings of the National Academy of Sciences.

[15]  Y. Janssen-Heininger,et al.  Arginase Modulates NF-κB Activity via a Nitric Oxide–Dependent Mechanism , 2007 .

[16]  M. Szmitkowski,et al.  Alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) in the cancer diseases. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[17]  P. Seifert,et al.  Alcohol Metabolism , 2020, Where Does All That Food Go?.

[18]  Limin Liu,et al.  Targeted deletion of GSNOR in hepatocytes of mice causes nitrosative inactivation of O6-alkylguanine-DNA alkyltransferase and increased sensitivity to genotoxic diethylnitrosamine , 2011, Carcinogenesis.

[19]  B. Gaston,et al.  S-nitrosoglutathione increases cystic fibrosis transmembrane regulator maturation. , 2001, Biochemical and biophysical research communications.

[20]  H. Edenberg,et al.  Genes Encoding Enzymes Involved in Ethanol Metabolism , 2012, Alcohol research : current reviews.

[21]  Limin Liu,et al.  Protection from Experimental Asthma by an Endogenous Bronchodilator , 2005, Science.

[22]  I Rovira,et al.  Nitric oxide , 2021, Reactions Weekly.

[23]  J. Buxbaum,et al.  Regeneration in the Era of Functional Genomics and Gene Network Analysis , 2011, The Biological Bulletin.

[24]  J. Stamler,et al.  Endogenous S-nitrosothiols protect against myocardial injury , 2009, Proceedings of the National Academy of Sciences.

[25]  Y. Rojanasakul,et al.  Nitrosothiol signaling and protein nitrosation in cell death. , 2014, Nitric oxide : biology and chemistry.

[26]  S. Mutka,et al.  Discovery of potent and novel S-nitrosoglutathione reductase inhibitors devoid of cytochrome P450 activities. , 2011, Bioorganic & medicinal chemistry letters.

[27]  L. Reis,et al.  Nitric oxide coating polypropylene mesh increases angiogenesis and reduces inflammatory response and apoptosis , 2017, International Urology and Nephrology.

[28]  C. Lutwak-Mann.  Alcohol dehydrogenase of animal tissues. , 1938, The Biochemical journal.

[29]  M. Xian,et al.  Direct methods for detection of protein S-nitrosylation. , 2013, Methods.

[30]  H. Edenberg.  The Genetics of Alcohol Metabolism , 2007 .

[31]  J. Stamler,et al.  Protein S-nitrosylation in health and disease: a current perspective. , 2009, Trends in molecular medicine.

[32]  S. Barnett,et al.  Agonist-Specific Compartmentation of cGMP Action in Myometrium , 2010, Journal of Pharmacology and Experimental Therapeutics.

[33]  Isabelle Romieu,et al.  Genetic variation in S-nitrosoglutathione reductase (GSNOR) and childhood asthma. , 2007, The Journal of allergy and clinical immunology.

[34]  A. Holmgren,et al.  The role of thioredoxin in the regulation of cellular processes by S-nitrosylation. , 2012, Biochimica et biophysica acta.

[35]  Jerry D. Cohen,et al.  Loss of GSNOR1 Function Leads to Compromised Auxin Signaling and Polar Auxin Transport. , 2015, Molecular plant.

[36]  B. Freeman,et al.  Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. , 1991, The Journal of biological chemistry.

[37]  J. Gelernter,et al.  ADH7 variation modulates extraversion and conscientiousness in substance‐dependent subjects , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[38]  B. Mroczko,et al.  The activity of class I, II, III and IV of alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) in the wall of abdominal aortic aneurysms. , 2009, Experimental and molecular pathology.

[39]  M. Hellgren,et al.  Medium- and short-chain dehydrogenase/reductase gene and protein families , 2008, Cellular and Molecular Life Sciences.

[40]  J. Stamler,et al.  Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis. , 2002, American journal of respiratory and critical care medicine.

[41]  M. Hanes,et al.  Hepatocarcinogenesis driven by GSNOR deficiency is prevented by iNOS inhibition. , 2013, Cancer research.

[42]  H. Jörnvall,et al.  Mutation of Arg-115 of human class III alcohol dehydrogenase: a binding site required for formaldehyde dehydrogenase activity and fatty acid activation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[43]  G. Duester,et al.  Distribution of class I, III and IV alcohol dehydrogenase mRNAs in the adult rat, mouse and human brain. , 2003, European journal of biochemistry.

[44]  K. J. Patel,et al.  Endogenous Formaldehyde Is a Hematopoietic Stem Cell Genotoxin and Metabolic Carcinogen , 2015, Molecular cell.

[45]  D. Giustarini,et al.  Nitric oxide and S-nitrosothiols in human blood. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[46]  N. Todd,et al.  Pharmacological In Vivo Inhibition of S-Nitrosoglutathione Reductase Attenuates Bleomycin-Induced Inflammation and Fibrosis , 2015, The Journal of Pharmacology and Experimental Therapeutics.

[47]  R. Grafström,et al.  The Janus face of alcohol dehydrogenase 3. , 2009, Chemico-biological interactions.

[48]  W. Pryor,et al.  Oxidative chemistry of nitric oxide: the roles of superoxide, peroxynitrite, and carbon dioxide. , 1998, Free radical biology & medicine.

[49]  S. Moncada,et al.  The L-arginine-nitric oxide pathway. , 1993, The New England journal of medicine.

[50]  Weiming Xu,et al.  The role of nitric oxide in cancer , 2002, Cell Research.

[51]  Gert Folkerts,et al.  Nitric Oxide in Health and Disease of the Respiratory System , 2022 .

[52]  J. I. Izpisúa Belmonte,et al.  A Novel Suppressive Effect of Alcohol Dehydrogenase 5 in Neuronal Differentiation* , 2014, The Journal of Biological Chemistry.

[53]  Ting-kai Li,et al.  Research advances in ethanol metabolism. , 2001, Pathologie-biologie.

[54]  A. Holmgren,et al.  Thioredoxin and thioredoxin reductase in relation to reversible S-nitrosylation. , 2013, Antioxidants & redox signaling.

[55]  J. Farrés,et al.  Physiological substrates for rat alcohol dehydrogenase classes: aldehydes of lipid peroxidation, omega-hydroxyfatty acids, and retinoids. , 1993, Archives of biochemistry and biophysics.

[56]  Vinod Jyothikumar,et al.  Hypoxia-induced changes in protein s-nitrosylation in female mouse brainstem. , 2015, American journal of respiratory cell and molecular biology.

[57]  T. Hurley,et al.  Human glutathione-dependent formaldehyde dehydrogenase. Structural changes associated with ternary complex formation. , 2002, Biochemistry.

[58]  J. Stamler,et al.  Cysteine-3635 is responsible for skeletal muscle ryanodine receptor modulation by NO , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[59]  C. Nathan,et al.  Nitric oxide and macrophage function. , 1997, Annual review of immunology.

[60]  X. Parés,et al.  S-nitrosoglutathione reductase activity of human and yeast glutathione-dependent formaldehyde dehydrogenase and its nuclear and cytoplasmic localisation , 2003, Cellular and Molecular Life Sciences CMLS.

[61]  T. Hurley,et al.  Human glutathione-dependent formaldehyde dehydrogenase , 2002 .

[62]  N. Bryan,et al.  Kinetic and Cellular Characterization of Novel Inhibitors of S-Nitrosoglutathione Reductase* , 2009, The Journal of Biological Chemistry.

[63]  J. Krystal,et al.  Association between common alcohol dehydrogenase gene (ADH) variants and schizophrenia and autism , 2013, Human Genetics.

[64]  D. Harrison,et al.  The physiology and pathophysiology of the nitric oxide/superoxide system , 1997, Herz.

[65]  F. J. Corpas,et al.  Function of S-nitrosoglutathione reductase (GSNOR) in plant development and under biotic/abiotic stress , 2011, Plant signaling & behavior.

[66]  N. A. Malmquist,et al.  NO‐induced relaxation of labouring and non‐labouring human myometrium is not mediated by cyclic GMP , 2001, British journal of pharmacology.

[67]  D. Wink,et al.  Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. , 1998, Free radical biology & medicine.

[68]  S. Mutka,et al.  Pharmacologic inhibition of S-nitrosoglutathione reductase protects against experimental asthma in BALB/c mice through attenuation of both bronchoconstriction and inflammation , 2014, BMC Pulmonary Medicine.

[69]  Y. Janssen-Heininger,et al.  Oxidative-nitrosative stress and post-translational protein modifications: implications to lung structure-function relations. Arginase modulates NF-kappaB activity via a nitric oxide-dependent mechanism. , 2007, American journal of respiratory cell and molecular biology.

[70]  A. Igamberdiev,et al.  Reactive Oxygen and Nitrogen Species Signaling and Communication in Plants , 2015, Signaling and Communication in Plants.

[71]  J. Höög,et al.  Mammalian alcohol dehydrogenase of higher classes: analyses of human ADH5 and rat ADH6. , 2001, Chemico-biological interactions.

[72]  K. Shokat,et al.  Human Carbonyl Reductase 1 Is an S-Nitrosoglutathione Reductase* , 2008, Journal of Biological Chemistry.

[73]  L. Samson,et al.  Regulation of DNA Repair , 2001 .

[74]  Craig C. Ulrich,et al.  The human uterine smooth muscle S-nitrosoproteome fingerprint in pregnancy, labor, and preterm labor. , 2013, American journal of physiology. Cell physiology.

[75]  A. Ferro,et al.  Current status and future possibilities of nitric oxide-donor drugs: focus on S-nitrosothiols. , 2005, Mini-Reviews in Medical Chemistry.

[76]  M. Smith,et al.  Genetics of human alcohol and aldehyde dehydrogenases. , 1986, Advances in human genetics.

[77]  H. Jörnvall,et al.  Recommended nomenclature for the vertebrate alcohol dehydrogenase gene family. , 1999, Biochemical pharmacology.

[78]  P. López-Jaramillo,et al.  The L-arginine: nitric oxide pathway. , 1993, Current opinion in nephrology and hypertension.

[79]  I. Buxton.  Regulation of uterine function: a biochemical conundrum in the regulation of smooth muscle relaxation. , 2004, Molecular pharmacology.

[80]  J. Stamler,et al.  S-nitrosoglutathione reductase: an important regulator in human asthma. , 2009, American journal of respiratory and critical care medicine.

[81]  D. Colagiovanni,et al.  A nonclinical safety and pharmacokinetic evaluation of N6022: a first-in-class S-nitrosoglutathione reductase inhibitor for the treatment of asthma. , 2012, Regulatory toxicology and pharmacology : RTP.

[82]  S. Yin,et al.  The metabolic role of human ADH3 functioning as ethanol dehydrogenase , 2003, FEBS letters.

[83]  Solomon H. Snyder,et al.  The Biotin Switch Method for the Detection of S-Nitrosylated Proteins , 2001, Science's STKE.

[84]  L. Palmer,et al.  Gender Differences in S-Nitrosoglutathione Reductase Activity in the Lung , 2010, PloS one.

[85]  J. Postlethwait,et al.  Oikopleura dioica Alcohol Dehydrogenase Class 3 Provides New Insights into the Evolution of Retinoic Acid Synthesis in Chordates , 2010, Zoological science.

[86]  H. E. Marshall,et al.  Protein S-nitrosylation: purview and parameters , 2005, Nature Reviews Molecular Cell Biology.

[87]  M. Anvret,et al.  Alcohol dehydrogenase alleles in Parkinson's disease , 2000, Movement disorders : official journal of the Movement Disorder Society.

[88]  D. Fell,et al.  Contribution of NADH increases to ethanol's inhibition of retinol oxidation by human ADH isoforms. , 2009, Alcoholism, clinical and experimental research.

[89]  D. Jensen,et al.  S-Nitrosoglutathione is a substrate for rat alcohol dehydrogenase class III isoenzyme. , 1998, The Biochemical journal.

[90]  H. Robinson,et al.  Structure-function relationships in human glutathione-dependent formaldehyde dehydrogenase. Role of Glu-67 and Arg-368 in the catalytic mechanism. , 2006, Biochemistry.

[91]  A. Burnett,et al.  Transnitrosylation: A Factor in Nitric Oxide-Mediated Penile Erection. , 2016, The journal of sexual medicine.

[92]  Lauro M. Takeuchi,et al.  S-Nitrosoglutathione Reductase Deficiency Enhances the Proliferative Expansion of Adult Heart Progenitors and Myocytes Post Myocardial Infarction , 2015, Journal of the American Heart Association.

[93]  J. Kulbacka,et al.  [Reactive oxygen and nitrogen species]. , 2011, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.

[94]  Mathew W. Wright,et al.  Guidelines for human gene nomenclature. , 2002, Genomics.

[95]  W. MacNee,et al.  Oxidative stress and regulation of glutathione in lung inflammation. , 2000, The European respiratory journal.

[96]  E. Ashley,et al.  Nitric oxide control of cardiac function: is neuronal nitric oxide synthase a key component? , 2004, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[97]  G. Rosenthal,et al.  Mechanism of inhibition for N6022, a first-in-class drug targeting S-nitrosoglutathione reductase. , 2012, Biochemistry.

[98]  G. Pfitzer,et al.  Regulation of smooth muscle contraction by small GTPases. , 2009, Physiology.

[99]  G. Chau,et al.  Functional assessment of human alcohol dehydrogenase family in ethanol metabolism: significance of first-pass metabolism. , 2006, Alcoholism, clinical and experimental research.

[100]  Brian C. Smith,et al.  Mechanisms of S-nitrosothiol formation and selectivity in nitric oxide signaling. , 2012, Current opinion in chemical biology.

[101]  P. Wang,et al.  Nitric oxide metabolism controlled by formaldehyde dehydrogenase (fdh, homolog of mammalian GSNOR) plays a crucial role in visual pattern memory in Drosophila. , 2011, Nitric oxide : biology and chemistry.

[102]  S. O’Brien,et al.  Cloning and comparative mapping of a human class III (chi) alcohol dehydrogenase cDNA. , 1989, Biochemical and biophysical research communications.

[103]  J. R. Lancaster.  Protein cysteine thiol nitrosation: maker or marker of reactive nitrogen species-induced nonerythroid cellular signaling? , 2008, Nitric oxide : biology and chemistry.

[104]  S. Mutka,et al.  Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement. , 2011, Bioorganic & medicinal chemistry letters.

[105]  K. Zaman,et al.  Novel s-nitrosothiols have potential therapeutic uses for cystic fibrosis. , 2013, Current pharmaceutical design.

[106]  K. Marinković,et al.  Alcoholism and the Brain: An Overview , 2003, Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism.

[107]  H. Hirt,et al.  Reactive oxygen species: metabolism, oxidative stress, and signal transduction. , 2004, Annual review of plant biology.

[108]  U. Walter,et al.  NO at work , 1994, Cell.

[109]  R. Stevens,et al.  Responses of normal and sickle cell hemoglobin to S-nitroscysteine: implications for therapeutic applications of NO in treatment of sickle cell disease. , 2002, Biophysical chemistry.

[110]  H. Jörnvall,et al.  Rat liver alcohol dehydrogenase of class III. Primary structure, functional consequences and relationships to other alcohol dehydrogenases. , 1988, European journal of biochemistry.

[111]  J. Daniel.  Adaptation and immunity of lower organisms to ethyl alcohol , 1909, Archiv für Entwicklungsmechanik der Organismen.

[112]  Bin Li,et al.  S-Nitrosylation from GSNOR Deficiency Impairs DNA Repair and Promotes Hepatocarcinogenesis , 2010, Science Translational Medicine.

[113]  T. Yonetani,et al.  On the effects of some heterocyclic compounds on the enzymic activity of liver alcohol dehydrogenase. , 1969, Acta chemica Scandinavica.

[114]  B. Vallee,et al.  Human liver class III alcohol and glutathione dependent formaldehyde dehydrogenase are the same enzyme. , 1991, Biochemical and biophysical research communications.

[115]  I. Buxton,et al.  Nitric oxide relaxes human myometrium by a cGMP-independent mechanism. , 1998, American journal of physiology. Cell physiology.

[116]  D. Giustarini,et al.  Protein S-glutathionylation: a regulatory device from bacteria to humans. , 2009, Trends in biochemical sciences.

[117]  J. Stamler,et al.  S-nitrosylation in health and disease. , 2003, Trends in molecular medicine.

[118]  J. Stamler,et al.  GSNO reductase and β2-adrenergic receptor gene–gene interaction: bronchodilator responsiveness to albuterol , 2010, Pharmacogenetics and genomics.

[119]  D. Thomas,et al.  S-nitrosation: current concepts and new developments. , 2012, Antioxidants & redox signaling.

[120]  R. Locksley,et al.  Lymphocyte Development Requires S-nitrosoglutathione Reductase , 2010, The Journal of Immunology.

[121]  M. Terry,et al.  S-nitrosothiols dilate the mesenteric artery more potently than the femoral artery by a cGMP and L-type calcium channel-dependent mechanism. , 2016, Nitric oxide : biology and chemistry.

[122]  P. Klatt,et al.  Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress. , 2000, European journal of biochemistry.

[123]  H. Edenberg,et al.  Cloning and characterization of the ADH5 gene encoding human alcohol dehydrogenase 5, formaldehyde dehydrogenase. , 1992, Gene.

[124]  U. Bronas,et al.  Reactive Oxygen and Nitrogen Species: Impact on Endothelial Dysfunction , 2015, Nursing research.

[125]  K. Bowers,et al.  Glutathione pathway gene variation and risk of autism spectrum disorders , 2011, Journal of Neurodevelopmental Disorders.

[126]  T. Hurley,et al.  Structure of human chi chi alcohol dehydrogenase: a glutathione-dependent formaldehyde dehydrogenase. , 1996, Journal of molecular biology.

[127]  B. Vallee,et al.  chi-ADH is the sole alcohol dehydrogenase isozyme of mammalian brains: implications and inferences. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[128]  K. Homma,et al.  cGMP-Dependent Relaxation of Smooth Muscle Is Coupled With the Change in the Phosphorylation of Myosin Phosphatase , 2007, Circulation research.

[129]  R. Grafström,et al.  Expression of alcohol dehydrogenase 3 in tissue and cultured cells from human oral mucosa. , 2000, The American journal of pathology.

[130]  F. Cecconi,et al.  S-Nitrosoglutathione Reductase Plays Opposite Roles in SH-SY5Y Models of Parkinson's Disease and Amyotrophic Lateral Sclerosis , 2015, Mediators of inflammation.

[131]  R. Albalat,et al.  Merging protein, gene and genomic data: the evolution of the MDR-ADH family , 2005, Heredity.

[132]  A. Sawa,et al.  Nitric oxide signaling and nitrosative stress in neurons: role for S-nitrosylation. , 2011, Antioxidants & redox signaling.

[133]  D. Leibfritz,et al.  Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.

[134]  H. E. Marshall,et al.  Essential Roles of S-Nitrosothiols in Vascular Homeostasis and Endotoxic Shock , 2004, Cell.

[135]  E. Seeley,et al.  Increased susceptibility to Klebsiella pneumonia and mortality in GSNOR-deficient mice. , 2013, Biochemical and biophysical research communications.

[136]  W. Griffiths,et al.  Reduction of S-nitrosoglutathione by human alcohol dehydrogenase 3 is an irreversible reaction as analysed by electrospray mass spectrometry. , 2003, European journal of biochemistry.

[137]  J. Stamler,et al.  S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[138]  H. Jörnvall,et al.  cDNA sequence of human class III alcohol dehydrogenase. , 1989, Biochemical and biophysical research communications.

[139]  M. Fukuzawa,et al.  Role of Nitric Oxide in the Colon of Patients With Slow-Transit Constipation , 2002, Diseases of the colon and rectum.

[140]  N. Bryan,et al.  Nebivolol Acts as a S-Nitrosoglutathione Reductase Inhibitor , 2016, Journal of cardiovascular pharmacology and therapeutics.

[141]  G. Loake,et al.  Nitric oxide and S-nitrosoglutathione function additively during plant immunity. , 2016, The New phytologist.

[142]  Limin Liu,et al.  S-nitrosoglutathione reductase deficiency increases mutagenesis from alkylation in mouse liver. , 2013, Carcinogenesis.

[143]  Edward T Chouchani,et al.  Mitochondria selective S-nitrosation by mitochondria-targeted S-nitrosothiol protects against post-infarct heart failure in mouse hearts , 2014, European journal of heart failure.

[144]  X. Parés,et al.  Enhanced Formaldehyde Detoxification by Overexpression of Glutathione-Dependent Formaldehyde Dehydrogenase from Arabidopsis1 , 2003, Plant Physiology.

[145]  Solomon H. Snyder,et al.  Nitric oxide, a novel neuronal messenger , 1992, Neuron.

[146]  S. Mutka,et al.  Structure-activity relationship of pyrrole based S-nitrosoglutathione reductase inhibitors: carboxamide modification. , 2012, Bioorganic & medicinal chemistry letters.

[147]  H. Jörnvall,et al.  Class III human liver alcohol dehydrogenase: a novel structural type equidistantly related to the class I and class II enzymes. , 1988, Biochemistry.

[148]  S. Svensson,et al.  Class II alcohol dehydrogenase (ADH2)--adding the structure. , 2001, Chemico-biological interactions.

[149]  J. Stamler,et al.  Dynamic denitrosylation via S-nitrosoglutathione reductase regulates cardiovascular function , 2012, Proceedings of the National Academy of Sciences.

[150]  G. Leikauf.  Mechanisms of aldehyde-induced bronchial reactivity: role of airway epithelium. , 1992, Research report.

[151]  G. Duester,et al.  Stimulation of retinoic acid production and growth by ubiquitously expressed alcohol dehydrogenase Adh3 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[152]  G. Duester,et al.  Characterization of the functional gene encoding mouse class III alcohol dehydrogenase (glutathione-dependent formaldehyde dehydrogenase) and an unexpressed processed pseudogene with an intact open reading frame. , 1996, European journal of biochemistry.

[153]  C. Thompson,et al.  Mechanistic Considerations For Formaldehyde-Induced Bronchoconstriction Involving S-Nitrosoglutathione Reductase , 2007, Journal of toxicology and environmental health. Part A.

[154]  W. Lu,et al.  DNA damage and oxidative stress in human liver cell L‐02 caused by surface water extracts during drinking water treatment in a waterworks in China , 2009, Environmental and molecular mutagenesis.

[155]  A. Labbé,et al.  Étude de la voie métabolique de la vitamine A dans le poumon fœtal humain , 2011 .

[156]  B. Vallee,et al.  Hydrophobic anion activation of human liver chi chi alcohol dehydrogenase. , 1991, Biochemistry.

[157]  Scott M. Williams,et al.  Genetic variants of GSNOR and ADRB2 influence response to albuterol in African‐American children with severe asthma , 2009, Pediatric pulmonology.

[158]  A. Corti,et al.  Mechanisms and targets of the modulatory action of S-nitrosoglutathione (GSNO) on inflammatory cytokines expression. , 2014, Archives of biochemistry and biophysics.

[159]  A. Fajmut,et al.  Role of Protein Kinase Network in Excitation-Contraction Coupling in Smooth Muscle Cell , 2012 .

[160]  T. Hurley,et al.  Kinetic mechanism of human glutathione-dependent formaldehyde dehydrogenase. , 2000, Biochemistry.

[161]  M. Koivusalo,et al.  Evidence for the identity of glutathione‐dependent formaldehyde dehydrogenase and class III alcohol dehydrogenase , 1989, FEBS letters.

[162]  B. Gaston,et al.  SNOR and wheeze: the asthma enzyme? , 2005, Trends in molecular medicine.

[163]  Keith N. Ballard,et al.  S-Nitrosation of Conserved Cysteines Modulates Activity and Stability of S-Nitrosoglutathione Reductase (GSNOR). , 2016, Biochemistry.

[164]  B. Gaston,et al.  Decreased levels of nitrosothiols in the lower airways of patients with cystic fibrosis and normal pulmonary function. , 1999, The Journal of pediatrics.

[165]  J. Kochanowicz,et al.  The Activity of Class I, II, III and IV of Alcohol Dehydrogenase (ADH) Isoenzymes and Aldehyde Dehydrogenase (ALDH) in Brain Cancer , 2013, Neurochemical Research.

[166]  C. Bonaventura,et al.  Effects of S-Nitrosation on Oxygen Binding by Normal and Sickle Cell Hemoglobin* , 1999, The Journal of Biological Chemistry.

[167]  J. Schrader,et al.  Control of coronary vascular tone by nitric oxide. , 1990, Circulation research.

[168]  Limin Liu,et al.  Regulation of DNA repair by S-nitrosylation. , 2012, Biochimica et biophysica acta.

[169]  M. Zeng,et al.  A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans , 2001, Nature.

[170]  H. Edenberg.  The Genetics of Alcohol Metabolism: Role of Alcohol Dehydrogenase and Aldehyde Dehydrogenase Variants , 2007, Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism.

[171]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[172]  J. Carvalheira,et al.  S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance. , 2005, Diabetes.

[173]  Katarzyna A. Broniowska,et al.  The chemical biology of S-nitrosothiols. , 2012, Antioxidants & redox signaling.

[174]  Santiago Lamas,et al.  S-nitrosylation: a potential new paradigm in signal transduction. , 2004, Cardiovascular research.

[175]  M. Adinolfi,et al.  Immunological and biochemical characterization of the human alcohol dehydrogenase χ‐ADH isozyme , 1984 .

[176]  B. Vallee,et al.  Physical and enzymatic properties of a class III isozyme of human liver alcohol dehydrogenase: chi-ADH. , 1984, Biochemistry.

[177]  K. Channon,et al.  Nitric Oxide Modulates Superoxide Release and Peroxynitrite Formation in Human Blood Vessels , 2002, Hypertension.

[178]  R. Grafström,et al.  Reduction of S-nitrosoglutathione by alcohol dehydrogenase 3 is facilitated by substrate alcohols via direct cofactor recycling and leads to GSH-controlled formation of glutathione transferase inhibitors. , 2008, The Biochemical journal.

[179]  N. Westerhof,et al.  Nitric oxide and cardiac function. , 2007, Life sciences.

[180]  Craig C. Ulrich,et al.  Uterine Smooth Muscle S-Nitrosylproteome in Pregnancy , 2012, Molecular Pharmacology.

[181]  J S Beckman,et al.  Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.

[182]  C. Gargioli,et al.  S-nitrosoglutathione reductase deficiency-induced S-nitrosylation results in neuromuscular dysfunction. , 2014, Antioxidants & redox signaling.

[183]  M. O. Bradley,et al.  S-Nitrosoglutathione Reductase Inhibition Regulates Allergen-Induced Lung Inflammation and Airway Hyperreactivity , 2013, PloS one.

[184]  L. Liaudet,et al.  Nitric oxide and peroxynitrite in health and disease. , 2007, Physiological reviews.

[185]  J. Stamler,et al.  Protein denitrosylation: enzymatic mechanisms and cellular functions , 2009, Nature Reviews Molecular Cell Biology.